Cisplatin 1 mg/mL (Cisplatin INJECTION, SOLUTION) 1 mg/mL

Cisplatin 1 mg/mL is an injectable solution used for various medical treatments. This intravenous medication is manufactured by Sagent Pharmaceuticals in the USA.

Strength

1 mg/mL

Pack Size

1 VIAL in 1 CARTON (25021-253-51) / 100 mL in 1 VIAL

Manufacturer / TM Owner

Sagent Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cisplatin 1 mg/mL is primarily used in the treatment of certain types of cancer. It works by interfering with the growth of cancer cells. The specific uses of Cisplatin 1 mg/mL can vary, and it is often prescribed by healthcare professionals for conditions that require chemotherapy.

Side Effects

Common effects of Cisplatin 1 mg/mL may include nausea, vomiting, and fatigue. Some individuals may also experience hair loss and changes in taste. These effects can vary from person to person, and it is important to discuss any concerns with a healthcare provider.

Precautions & Warnings

Cisplatin 1 mg/mL should be handled with care and administered by a healthcare professional. It is important to follow all instructions provided by the prescribing doctor. This medication should not be used without proper medical supervision.

Avoid Interactions

Cisplatin 1 mg/mL may interact with other medications, including certain antibiotics and diuretics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.

Frequently Asked Questions

Cisplatin 1 mg/mL is used in the treatment of certain types of cancer. It is a chemotherapy drug that interferes with the growth of cancer cells.

Cisplatin 1 mg/mL is administered intravenously by a healthcare professional. It is important to follow all instructions provided by the prescribing doctor.

Common side effects of Cisplatin 1 mg/mL may include nausea, vomiting, fatigue, hair loss, and changes in taste.

Cisplatin 1 mg/mL may interact with other medications, including certain antibiotics and diuretics. It is important to inform your healthcare provider about all medications you are taking.

Cisplatin 1 mg/mL should be handled with care and administered by a healthcare professional. It is important to follow all instructions provided by the prescribing doctor.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.